Take a look at our newest feature in Hospitecnia, written by Rafael Sanmartin de la Fuente, Quibim's Digital Security Manager, and María José Alarte, Director of Legal. We delve into the crucial topic of digitalization in #healthcare services and how it brings numerous advantages but also associated risks. The safeguarding of health #data is inherently linked with cybersecurity matters. According to data from Spain's National Cybersecurity Institute, INCIBE - Instituto Nacional de Ciberseguridad, in 2022, #cyberattacks in the healthcare sector fall into five main categories: exposed/vulnerable systems (60.81%), information theft (20.88%), fraud (6.59%), intrusions (4.76%), and malware (4.76%). At Quibim, we are committed to safeguarding healthcare data, employing robust security measures and staying at the forefront of #cybersecurity developments. By staying vigilant and proactive, we can mitigate risks and protect the confidentiality and integrity of patients' information. To access the complete article (in Spanish), click here! https://bit.ly/3CWKcH3
Meet Anna Nogué Infante, our Project Manager in the Clinical Trials Department at Quibim. Anna's steadfast dedication to discovering new #ImagingBiomarkers is crucial in our quest to improve #patientcare outcomes. Collaborating on grant-funded projects and leading research projects with leading pharmaceutical and biotech companies or international hospitals, she ensures that our company remains at the forefront of #healthcare. Passionate about every new achievement and discovery, her teamwork efforts and vision inspire everyone around her. Anna is proud to be a Quibimer, and we couldn't be happier to have her on board! #beaquibimer
We made significant progress during the #ProCanAid consortium meeting at Hospital La Fe de Valencia on May 24th. Over this event, exciting discussions were held to highlight our advancements in the project and outline the future direction of the revolutionizing initiative of creating a prostate #DigitalTwin that can predict treatments and their effectiveness. As the central coordinator, Quibim continues to join forces with La Fe Health Research Institute | IIS La Fe and Universidad de Zaragoza, to drive innovation to transform #prostatecancer and work towards a future where personalized medicine truly transforms #patientcare.
Did you know that #AI-driven technology is revolutionizing #healthcare? At Quibim, we are at the forefront of this transformation, designing comprehensive solutions for the management and processing of medical image #data. Our products enable analysis and extraction of new insights from multi-modality images by linking electronic health records and #patientoutcomes with imaging biomarkers. This improves patient stratification and generates precise clinical endpoints for more effective treatment.
🧠 QP-Brain is our innovative #AI-driven solution for brain #MRI analysis. It integrates with clinical workflows, offering automated, precise insights into brain tissue quickly and efficiently.
During yesterday and today, our team is participating in the RadioVal Consortium Meeting in Barcelona! This is a great opportunity to gather with industry leaders to share our groundbreaking work and advancements in the project. At Quibim, we strongly believe in the power of machine learning to revolutionize #breastcancer treatment. That's why we are proud to be part of this project, which aims to implement a comprehensive validation of #AI solutions in this critical area. We're excited about our progress and the positive impact it will have on #patientcare worldwide. Together, we're working towards more accurate diagnoses, personalized treatment plans, and improved patient outcomes.
Having a Chief Medical Officer is crucial to bridge the gap between clinical practice and #biotech innovations, ensuring that our solutions are not only cutting-edge but also clinically relevant. When discussing the future of #medicalimaging, our CMO, Dr. Glen Weiss, MD, MBA, emphasizes the importance of incorporating innovative tools into imaging software and #data analytics. He envisions a future where these tools enable more precise lesion identification and provides volumetric data, ultimately enhancing the effectiveness of therapy for patients. Read more here! https://bit.ly/41PHkGi
#ESGAR2023 is now live! At this annual meeting, we present specialists with an updated overview of the gastrointestinal and abdominal radiology field. If you are in Valencia, we invite you to visit us at booth number 11 and discover QP-Liver, our AI-assisted, accurate, and automated liver segmentation tool. European Society of Gastrointestinal and Abdominal Radiology - ESGAR
Transforming #liverdisease #diagnosis: using Convolutional Neural Networks (CNN) for automatic liver #segmentation and #quantification in MRI imaging. https://bit.ly/3NaWT66 This novel methodology addresses existing challenges in diagnosing diseases like NAFLD and NASH, overcoming limitations of previous methods. The CNN model demonstrates high accuracy, with a 94% median Dice coefficient and a low false discovery rate. It quantifies key biomarkers with minimal errors, improving our capacity in diagnosing and monitoring liver diseases. This automated approach offers radiologists invaluable insights while reducing manual segmentation limitations. It paves the way for fast, automated MR virtual biopsies, opening new possibilities in liver disease #research and #treatment. Stay tuned for more advancements in health tech! #AI #healthtech #precisionmedicine
Our team members Ana María Blanco Sánchez, PhD, PMP® and Fuensanta Bellvís Bataller are currently participating in the consortium meeting for the #PainFACT project in Reykjavik. They're joining partners from around the globe to share the progress we've made on the project. The primary objective of PainFACT is to uncover the mechanisms associated with #chronicpain. It's a privilege for us to collaborate with all the partners as we continue striving to identify molecular mechanisms and develop #predictivealgorithms for new-onset chronic pain and pain-related comorbidity.
